BETA


2016/3029(RSP) Resolution on support for the thalidomide survivors

Progress: Procedure completed

Legal Basis:
RoP 132-p2

Events

2016/12/15
   EP - Results of vote in Parliament
2016/12/15
   EP - Decision by Parliament
Details

The European Parliament adopted a resolution on support for the thalidomide survivors.

The text adopted in plenary was tabled by the EPP, S&D, ECR, ALDE, GUE/NGL and Greens/EFA groups.

Members recalled that the drug thalidomide was marketed by Chemie Grünenthal GmbH in the late 1950s and early 1960s as a safe drug to treat morning sickness, headaches, coughs, insomnia and the common cold.

This drug resulted in the death and malformation of thousands of babies when taken by pregnant women in many European countries.

Furthermore, independently verified research points to an inexorable inference that in 1970 the Federal Republic of Germany interfered with the criminal proceedings against Chemie Grünenthal GmbH, the German manufacturer of thalidomide. As a consequence, no proper determination of the guilt of the manufacturer could be established.

Against this background, Parliament urged the Member States and the Commission to coordinate actions and measures seeking to formally recognise and provide compensation to thalidomide survivor.

Parliament urged the German Federal Government to use the opportunity presented by the forthcoming amendment to the Thalidomide Foundation Act to allow thalidomide survivors, who have been accredited as such by court-appointed trust schemes or are beneficiaries of national government schemes, to access the Special Health Fund of the German Conterganstiftung für behinderte Menschen (Thalidomide Foundation for People with Disabilities).

Parliament urged the Commission to create a framework protocol at European level under which all European citizens affected by thalidomide would receive similar amounts of compensation , regardless of which Member State they are from, and to draw up an EU programme for assistance and support (including both financial and welfare provisions) for thalidomide victims and their families.

Lastly, Members asked the Grünenthal company to shoulder its responsibilities by providing proper compensation and care to those victims who have yet to be recognised.

Documents
2016/12/15
   EP - End of procedure in Parliament
2016/12/14
   EP - Motion for a resolution
Documents
2016/12/14
   EP - Motion for a resolution
Documents
2016/12/14
   EP - Debate in Parliament

Documents

Activities

Votes

B8-1341/2016 - Am 1 #

2016/12/15 Outcome: +: 457, -: 166, 0: 17
GB ES DE NL FR BE IT EL SE PT RO DK FI CZ AT PL LT EE BG LU IE CY HR MT SK LV SI HU
Total
52
46
81
24
61
20
59
18
19
19
26
12
11
19
18
48
8
6
15
5
9
5
11
5
12
6
7
17
icon: S&D S&D
170

Netherlands S&D

3

Lithuania S&D

1

Estonia S&D

For (1)

1
3

Luxembourg S&D

For (1)

1

Ireland S&D

For (1)

1

Cyprus S&D

2

Croatia S&D

2

Malta S&D

3
3

Latvia S&D

1
icon: ALDE ALDE
60

Portugal ALDE

1

Romania ALDE

3

Austria ALDE

For (1)

1

Estonia ALDE

3

Luxembourg ALDE

For (1)

1

Ireland ALDE

For (1)

1

Croatia ALDE

2

Slovenia ALDE

For (1)

1
icon: ECR ECR
57

Netherlands ECR

2

Italy ECR

1

Greece ECR

For (1)

1

Romania ECR

For (1)

1
2

Czechia ECR

2

Lithuania ECR

1

Bulgaria ECR

2

Croatia ECR

For (1)

1
icon: GUE/NGL GUE/NGL
43

Netherlands GUE/NGL

3

Sweden GUE/NGL

For (1)

1

Denmark GUE/NGL

For (1)

1

Finland GUE/NGL

For (1)

1

Czechia GUE/NGL

2

Ireland GUE/NGL

3

Cyprus GUE/NGL

2
icon: Verts/ALE Verts/ALE
41

United Kingdom Verts/ALE

4

Netherlands Verts/ALE

2

Belgium Verts/ALE

2

Sweden Verts/ALE

3

Denmark Verts/ALE

For (1)

1

Austria Verts/ALE

3

Estonia Verts/ALE

For (1)

1

Luxembourg Verts/ALE

For (1)

1

Croatia Verts/ALE

For (1)

1

Latvia Verts/ALE

1

Slovenia Verts/ALE

For (1)

1

Hungary Verts/ALE

2
icon: ENF ENF
33

United Kingdom ENF

For (1)

1

Germany ENF

For (1)

1

Belgium ENF

For (1)

1

Poland ENF

For (1)

1
icon: NI NI
16

United Kingdom NI

3

Germany NI

2

France NI

Abstain (1)

2

Italy NI

For (1)

1

Poland NI

1

Hungary NI

2
icon: EFDD EFDD
34

France EFDD

1

Sweden EFDD

2

Poland EFDD

1

Lithuania EFDD

For (1)

1
icon: PPE PPE
185

Belgium PPE

4

Denmark PPE

Against (1)

1

Finland PPE

Against (1)

3

Lithuania PPE

2

Estonia PPE

Against (1)

1

Luxembourg PPE

For (1)

Against (1)

2

Ireland PPE

For (1)

4

Cyprus PPE

Against (1)

1

Malta PPE

2

History

(these mark the time of scraping, not the official date of the change)

docs/0/docs/0/url
Old
http://www.europarl.europa.eu/doceo/document/B-8-2016-1341_EN.html
New
https://www.europarl.europa.eu/doceo/document/B-8-2016-1341_EN.html
docs/1/docs/0/url
Old
http://www.europarl.europa.eu/doceo/document/B-8-2016-1343_EN.html
New
https://www.europarl.europa.eu/doceo/document/B-8-2016-1343_EN.html
events/0/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=20161214&type=CRE
New
https://www.europarl.europa.eu/doceo/document/CRE-8-2016-12-14-TOC_EN.html
events/2
date
2016-12-15T00:00:00
type
Decision by Parliament
body
EP
docs
url: https://www.europarl.europa.eu/doceo/document/TA-8-2016-0510_EN.html title: T8-0510/2016
summary
events/2
date
2016-12-15T00:00:00
type
Decision by Parliament, 1st reading/single reading
body
EP
docs
url: http://www.europarl.europa.eu/doceo/document/TA-8-2016-0510_EN.html title: T8-0510/2016
summary
docs/0/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=MOTION&reference=B8-2016-1341&language=EN
New
http://www.europarl.europa.eu/doceo/document/B-8-2016-1341_EN.html
docs/1/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=MOTION&reference=B8-2016-1343&language=EN
New
http://www.europarl.europa.eu/doceo/document/B-8-2016-1343_EN.html
events/2/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2016-0510
New
http://www.europarl.europa.eu/doceo/document/TA-8-2016-0510_EN.html
activities
  • date: 2016-12-14T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=20161214&type=CRE type: Debate in Parliament title: Debate in Parliament body: EP type: Debate in Parliament
  • date: 2016-12-15T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2016-0510 type: Decision by Parliament, 1st reading/single reading title: T8-0510/2016 body: EP type: Decision by Parliament, 1st reading/single reading
committees
    docs
    • date: 2016-12-14T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=MOTION&reference=B8-2016-1341&language=EN title: B8-1341/2016 type: Motion for a resolution body: EP
    • date: 2016-12-14T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=MOTION&reference=B8-2016-1343&language=EN title: B8-1343/2016 type: Motion for a resolution body: EP
    events
    • date: 2016-12-14T00:00:00 type: Debate in Parliament body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=20161214&type=CRE title: Debate in Parliament
    • date: 2016-12-15T00:00:00 type: Results of vote in Parliament body: EP docs: url: https://oeil.secure.europarl.europa.eu/oeil/popups/sda.do?id=28014&l=en title: Results of vote in Parliament
    • date: 2016-12-15T00:00:00 type: Decision by Parliament, 1st reading/single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2016-0510 title: T8-0510/2016 summary: The European Parliament adopted a resolution on support for the thalidomide survivors. The text adopted in plenary was tabled by the EPP, S&D, ECR, ALDE, GUE/NGL and Greens/EFA groups. Members recalled that the drug thalidomide was marketed by Chemie Grünenthal GmbH in the late 1950s and early 1960s as a safe drug to treat morning sickness, headaches, coughs, insomnia and the common cold. This drug resulted in the death and malformation of thousands of babies when taken by pregnant women in many European countries. Furthermore, independently verified research points to an inexorable inference that in 1970 the Federal Republic of Germany interfered with the criminal proceedings against Chemie Grünenthal GmbH, the German manufacturer of thalidomide. As a consequence, no proper determination of the guilt of the manufacturer could be established. Against this background, Parliament urged the Member States and the Commission to coordinate actions and measures seeking to formally recognise and provide compensation to thalidomide survivor. Parliament urged the German Federal Government to use the opportunity presented by the forthcoming amendment to the Thalidomide Foundation Act to allow thalidomide survivors, who have been accredited as such by court-appointed trust schemes or are beneficiaries of national government schemes, to access the Special Health Fund of the German Conterganstiftung für behinderte Menschen (Thalidomide Foundation for People with Disabilities). Parliament urged the Commission to create a framework protocol at European level under which all European citizens affected by thalidomide would receive similar amounts of compensation , regardless of which Member State they are from, and to draw up an EU programme for assistance and support (including both financial and welfare provisions) for thalidomide victims and their families. Lastly, Members asked the Grünenthal company to shoulder its responsibilities by providing proper compensation and care to those victims who have yet to be recognised.
    • date: 2016-12-15T00:00:00 type: End of procedure in Parliament body: EP
    links
    other
      procedure/legal_basis/0
      Rules of Procedure EP 132-p2
      procedure/legal_basis/0
      Rules of Procedure of the European Parliament EP 123-p2
      procedure/subject
      Old
      • 4.20.01 Medicine, diseases
      • 4.20.05 Health legislation and policy
      New
      4.20.01
      Medicine, diseases
      4.20.05
      Health legislation and policy
      procedure/subtype
      Old
      Resolution on statements
      New
      Resolution on statement
      activities/1
      date
      2016-12-15T00:00:00
      docs
      url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2016-0510 type: Decision by Parliament, 1st reading/single reading title: T8-0510/2016
      body
      EP
      type
      Decision by Parliament, 1st reading/single reading
      procedure/stage_reached
      Old
      Awaiting Parliament 1st reading / single reading / budget 1st stage
      New
      Procedure completed
      activities/0/date
      Old
      2016-12-15T00:00:00
      New
      2016-12-14T00:00:00
      activities/0/docs
      • url: http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=20161214&type=CRE type: Debate in Parliament title: Debate in Parliament
      activities/0/type
      Old
      Vote in plenary scheduled
      New
      Debate in Parliament
      procedure/title
      Old
      Support for Thalidomide victims
      New
      Resolution on support for the thalidomide survivors
      activities/0
      date
      2016-12-14T00:00:00
      body
      EP
      type
      Debate in plenary scheduled
      activities
      • date: 2016-12-14T00:00:00 body: EP type: Debate in plenary scheduled
      • date: 2016-12-15T00:00:00 body: EP type: Vote in plenary scheduled
      committees
        links
        other
          procedure
          reference
          2016/3029(RSP)
          title
          Support for Thalidomide victims
          legal_basis
          Rules of Procedure of the European Parliament EP 123-p2
          stage_reached
          Awaiting Parliament 1st reading / single reading / budget 1st stage
          subtype
          Resolution on statements
          type
          RSP - Resolutions on topical subjects
          subject